Microfluidic Manufacturing Improves Polydispersity of Multicomponent Polymeric Nanoparticles


Authors: K. Abstiens and A.M. Goepferich

Journal: Journal of Drug Delivery Science and Technology

DOI: 10.1016/j.jddst.2018.12.009

Publication - Abstract

December 05, 2018

Abstract

A key challenge in manufacturing of multicomponent polymeric colloids is obtaining monodisperse nanoparticles (NPs) with reproducible characteristics. Herein, NP formulations with varying core to shell ratios were either prepared by bulk nanoprecipitation or microfluidic synthesis and evaluated regarding their size and polydispersity. Microfluidic process parameters, such as the total flow rate (TFR) and the flow rate ratio (FRR) of the aqueous phase and the organic polymer solution, were varied to tune particle size and further improve size distribution. In general, bulk nanoprecipitation resulted in formation of larger particles (52–65 nm) with a wide size distribution, whereas particles were significantly smaller in size (24–43 nm) and displayed a rather monodisperse size distribution when they were manufactured with a microfluidic system. The FRR was identified to be the key factor for improving the size distribution of NPs with a high ratio of PLA-PEG to PLGA, whereas it had only minor impact on particle characteristics of formulations with a lower copolymer ratio. Polydispersity of different NP formulations was successfully improved by microfluidic manufacturing, demonstrating that this technology is a valuable tool that allows for reproducible and scalable manufacturing of multicomponent NPs with precisely tunable quality attributes.

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Blog Posts
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Microfluidic-assisted Preparation of RGD-decorated Nanoparticles: Exploring Integrin-facilitated Uptake in Cancer Cell Lines

J.M. Rios De La Rosa, A. Spadea, R. Donno, E. Lallana, Y. Lu, S. Puri, P. Caswell, M. J. Lawrence, M. Ashford and N. Tirelli

Read More


Publication - Abstract

Abstract

Self-amplifying RNA (saRNA) is a cutting-edge platform for both nucleic acid vaccines and therapeutics. saRNA is self-adjuvanting, as it activates types I and III interferon (IFN), which enhances the immunogenicity of RNA vaccines but can also lead to inhibition...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.